Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström’s macroglobulinemia
暂无分享,去创建一个
R. Orlowski | B. Amini | Sheeba K. Thomas | D. Weber | E. Manasanch | Catherine M. Claussen | K. Patel | R. Steiner | M. Chaudhry | Hans C. Lee | C. Feng | Lei Feng